Tech Company Financing Transactions
SironRX Therapeutics Funding Round
North Coast Angel Fund, Early Stage Partners and Fletcher Spaght Ventures joined a $3.4 million Series A funding round for SironRX Therapeutics. The round was announced on 8/17/2011.
Transaction Overview
Company Name
Announced On
8/17/2011
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Series A
Investors
Proceeds Purpose
We will use the funds to build the SironRX team and execute on key clinical-stage milestones.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10000 Cedar Ave.
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Overview
SironRX is developing novel therapies exclusively licensed from Juventas Therapeutics and Cleveland Clinic that promote wound repair and prevent scarring of dermal wounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Evan Facher
Chief Medical Officer
Marc Penn
VP - Product Management
Timothy Miller
Browse more venture capital transactions:
Prev: 8/17/2011: Talk Market venture capital transaction
Next: 8/17/2011: ShowMe venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs